Loading quotes...
Forecast
The analysts' average price target is €27.63 (+141.52%). The median is €27.63 (+141.52%).
| Buy |
2 |
| Hold |
2 |
| Sell |
0 |
News Go to news feed
Nature's Sunshine targets $1 billion in sales after record Q2, cuts full-year guidance
Nature's Sunshine reported a record second quarter with $117 million in net sales and a 73.7% gross margin, but management lowered full-year net sales guidance to $490–500 million and trimmed EBITDA guidance amid currency headwinds and a 20% sales decline in China. North America digital sales rose 26% and social commerce jumped 177%, with autoship subscriptions gaining share, while SG&A and volume incentives increased as growth investments ramp. The company named Ruth Perkins CFO and Janine Weber president of North America to support a push to double sales, but risks remain from the China setback and a pressured North American direct-selling channel. » More on finance.yahoo.com
Nature’s Sunshine will double revenue to $1bn and increase EBITDA margin to 15%
Nature’s Sunshine presented at the growth conference a plan to accelerate growth through geographic expansion, digital D2C growth, targeted bolt‑on acquisitions and product innovations. The goal is to raise revenue from about $480m (2025) to $1bn and lift the EBITDA margin from 10% to 15%; the company has roughly $100m in cash and no debt. Key drivers are the fast‑growing digital business, the Asia‑Pacific region (40% of revenue) and an in‑house manufacturing capacity in Utah intended to enable economies of scale. Management emphasizes a disciplined M&A approach (target sizes $75–125m) and a multi‑channel strategy with separate product lines for advisors and digital channels. » More on de.investing.com
Nature’s Sunshine misses Q2 earnings and revenue forecasts, stock falls after hours
Nature’s Sunshine reported adjusted EPS of $0.21 for Q2 2026 on revenue of $117.0 million, both below consensus estimates ($0.29 and $123.7 million). Despite record sales for a second quarter and a gross margin of 73.7%, management cut the full-year outlook due to weaker sales in China and currency headwinds. The digital business grew strongly, with social commerce up 177%, while the North American direct selling business softened. The stock fell about 9.9% in after-hours trading; the company holds $82.5 million in cash and has no debt. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 102.5M | 5.29% |
| Gross profit | 75.51M | 8.14% |
| Net profit | 3.1M | 31.49% |
| EBITDA | 7.64M | 18.64% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €202.77M |
Number of shares | 17.6M |
52-week high/low | €25.08 - €10.62 |
| Dividends | No |
Beta | 0.81 |
P/E ratio | 12.68 |
PEG ratio | 0.37 |
P/B ratio | 1.36 |
P/S ratio | 0.46 |
Company profile
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
| Name | NATURE'S SUNSHINE PRODS |
| CEO | Kenneth G. Romanzi |
| Headquarters | Lehi,
ut USA |
| Website | |
| Sector | Materials |
| Industry | Chemicals |
| IPO | 06/25/2009 |
| Employees | 806 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | NATR |